Literature DB >> 15952130

[Clinical features and the mutation of Leber's hereditary optic neuropathy in Chinese patients].

Yan Wang1, Xiang-ming Guo, Xiao-yun Jia, Shi-qiang Li, Xue-shan Xiao, Li Guo, Qing-jiong Zhang.   

Abstract

OBJECTIVE: To analyze the mutation of Leber's hereditary optic neuropathy (LHON) and the clinical features in Chinese patients.
METHODS: The primary mtDNA mutations (3460A, 11778A and 14484C) of 156 patients (110 probands and 46 maternal relatives with LHON) were detected by mutation-specific priming polymerase chain reaction, heteroduplex-single strand conformation polymorphism polymerase chain reaction, restriction fragment length polymorphisms and measurement of DNA sequence. The clinical features were analyzed by retrospective study.
RESULTS: The 11778A mutation was found in 100 probands (90.9%), the 3460A mutation was found in 2 (1.8%), and the 14484C was found in 8 (7.3%) of the 110 probands. The visual acuity at onset of the disease was 0.01 or worse in 44 (17.6%) of 250 eyes with the 11778A mutation, but in none of 79 eyes with the 14484C mutation. The visual acuity was 0.1 or better in 76 (29.6%) of 250 eyes with the 11778A mutation, but in 49 (87.3%) of 56 eyes with the 14484C mutation. And 6.8% of 250 eyes with the 11778A mutation recovered a mean final visual acuity of 0.03, whereas 50% of 56 eyes with the 14484C mutation recovered a mean final visual acuity of 0.8.
CONCLUSION: In Chinese LHON patients the 11778A, 14484C primary mutations are common. The clinical features are associated with the site of primary mutation. The visual acuity at onset of the disease and the visual recovery of the eyes with 14484C mutation were better than the eyes with the 11778A mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15952130

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  5 in total

1.  A Meta-analysis of the association between different genotypes (G11778A, T14484C and G3460A) of Leber hereditary optic neuropathy and visual prognosis.

Authors:  Dong-Yu Guo; Xia-Wei Wang; Nan Hong; Yang-Shun Gu
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

2.  Fifteen novel mutations in the mitochondrial NADH dehydrogenase subunit 1, 2, 3, 4, 4L, 5 and 6 genes from Iranian patients with Leber's hereditary optic neuropathy (LHON).

Authors:  Zahra Rezvani; Elmira Didari; Ahoura Arastehkani; Vadieh Ghodsinejad; Omid Aryani; Behnam Kamalidehghan; Massoud Houshmand
Journal:  Mol Biol Rep       Date:  2013-10-24       Impact factor: 2.316

3.  Evaluation of Leber's hereditary optic neuropathy patients prior to a gene therapy clinical trial.

Authors:  Shuo Yang; Hong Yang; Si-Qi Ma; Shuai-Shuai Wang; Heng He; Min-Jian Zhao; Bin Li
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

4.  Prognostic factors for visual acuity in patients with Leber's hereditary optic neuropathy after rAAV2-ND4 gene therapy.

Authors:  Yong Zhang; Xin Li; Jiajia Yuan; Zhen Tian; Hongli Liu; Dan Wang; Bin Li
Journal:  Clin Exp Ophthalmol       Date:  2019-05-08       Impact factor: 4.207

5.  A retrospective analysis of characteristics of visual field damage in patients with Leber's hereditary optic neuropathy.

Authors:  Ruijin Ran; Shuo Yang; Heng He; Shiqi Ma; Zhiqi Chen; Bin Li
Journal:  Springerplus       Date:  2016-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.